Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Graft-versus-host Disease Prevention”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00670423
What this trial is testing

A Study Using Tacrolimus, Sirolimus and Bortezomib as Acute Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation

Who this might be right for
Graft vs Host DiseasePeripheral Blood Stem Cell TransplantationTransplantation, Homologous
Jennifer E. Schwartz 27
Testing effectiveness (Phase 2)Study completedNCT03128359
What this trial is testing

High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant

Who this might be right for
Acute LeukemiaChronic Lymphocytic Leukemia/Small Lymphocytic LymphomaChronic Myelogenous Leukemia, BCR-ABL1 Positive+12 more
City of Hope Medical Center 38
Testing effectiveness (Phase 2)Study completedNCT00948753
What this trial is testing

Maraviroc in Patients Undergoing Non-Myeloablative Allogeneic Stem-Cell Transplantation

Who this might be right for
Graft-versus-host DiseaseHematopoietic Stem Cell Transplantation
Abramson Cancer Center at Penn Medicine 38
Testing effectiveness (Phase 2)Study completedNCT02250300
What this trial is testing

MLN9708 for the Prophylaxis of Chronic Graft-versus-host Disease in Patient Undergoing Allogeneic Transplantation

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation
Mehdi Hamadani 68
Testing effectiveness (Phase 2)UnknownNCT06238245
What this trial is testing

Combination of ATG-based Conditioning Regimen and PTCy for GVHD Prevention in Allo-HSCT After PD-1 Blockade

Who this might be right for
Graft-versus-host DiseaseHematological Malignancies
Beijing 302 Hospital 22
Testing effectiveness (Phase 2)WithdrawnNCT05895201
What this trial is testing

High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Sitagliptin for the Prevention of GVHD

Who this might be right for
Bone Marrow Transplant ComplicationsAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia, Adult+2 more
Indiana University
Testing effectiveness (Phase 2)Active Not RecruitingNCT03842696
What this trial is testing

Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation

Who this might be right for
Hematologic DiseasesAcute Leukemia in RemissionChronic Myelogenous Leukemia - Chronic Phase+9 more
University of Michigan Rogel Cancer Center 43
Testing effectiveness (Phase 2)UnknownNCT05808985
What this trial is testing

Intestinal Microbiome-based Research for the Prevention of Acute GVHD

Who this might be right for
Graft Versus Host DiseasePostbioticsButyrate
Soonchunhyang University Hospital 15
Not applicableStudy completedNCT02409134
What this trial is testing

Cognitive Function and Patient-Reported Quality of Life Outcomes Investigation in Patients Taking Vorinostat

Who this might be right for
Quality of LifeGraft-vs-Host Disease
Sung Choi, M.D. 9
Testing effectiveness (Phase 2)Study completedNCT02206035
What this trial is testing

Tacrolimus/Methotrexate and Tocilizumab to Prevent Acute Graft-Versus-Host Disease (AGVD) After Allogeneic Hematopoietic Stem Cell Transplant

Who this might be right for
Hematopoietic Stem Cell Transplantation
William R. Drobyski, MD 45
Large-scale testing (Phase 3)UnknownNCT05158608
What this trial is testing

Comparison of PT-Cy at a Dose of 25 mg/kg/Day and PT-Cy at a Dose of 50 mg/kg/Day in GVHD Prophylaxis

Who this might be right for
Graft Versus Host DiseaseHematologic MalignancyCyclophosphamide Adverse Reaction
National Research Center for Hematology, Russia 100
Testing effectiveness (Phase 2)Looking for participantsNCT07570745
What this trial is testing

Low-Dose ATG/PTCy Plus Ivarmacitinib for aGVHD Prevention in Haplo-PBSCT From Parous Female Donors

Who this might be right for
Graft-Versus-Host Disease(GVHD)Bone Marrow Transplantation
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 82
Very early researchNot Yet RecruitingNCT06949267
What this trial is testing

IMSC for the Prevention of Acute Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Graft-versus-Host Disease
Ruijin Hospital 56
Not applicableEnded earlyNCT02338232
What this trial is testing

Study of TelmisartanFor the Prevention of Acute GVHD Post Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
GVHD
Hackensack Meridian Health 32
Testing effectiveness (Phase 2)Ended earlyNCT03263767
What this trial is testing

Post Transplant Cyclophosphamide (PTCY) as Sole Graft Versus Host Disease (GVHD) Prophylaxis for Matched Allotransplant: CYRIC

Who this might be right for
Graft Versus Host Disease
Nantes University Hospital 47
Testing effectiveness (Phase 2)Study completedNCT00691015
What this trial is testing

Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+3 more
Barbara Ann Karmanos Cancer Institute 48
Not applicableStudy completedNCT07355517
What this trial is testing

Guided Biofilm Therapy Compared to Traditional Cleaning for Treating Gingival Inflammation in Orthodontic Patients

Who this might be right for
Gingivitis and Periodontal DiseasesGingivitis; ChronicGingivitis+3 more
King Abdullah University Hospital 30
Very early researchStudy completedNCT03529825
What this trial is testing

Rifaximin for Infection Prophylaxis in Hematopoietic Stem Cell Transplantation

Who this might be right for
Microbial Colonization
Emory University 26
Testing effectiveness (Phase 2)Ended earlyNCT03456817
What this trial is testing

HIgh Dose Thymoglobulin Instead of Cyclosporine With a Low Dose of Thymoglobulin for GVHD Prophylaxis

Who this might be right for
Graft-versus-host-diseaseRelapse
AHS Cancer Control Alberta 68
Testing effectiveness (Phase 2)Ended earlyNCT02737306
What this trial is testing

Acute Graft-Versus-Host Disease (GVHD) in Patients Undergoing Allogeneic Stem-Cell Transplantation

Who this might be right for
Graft Vs Host Disease
CytoDyn, Inc. 11
Next Page